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It is well established that cell survival signals stimulated by growth factors, cytokines, and oncoproteins are
initiated by phosphoinositide 3-kinase (PI3K)- and Akt-dependent signal transduction pathways. Oncogenic
Ras, an upstream activator of Akt, requires NF-kB to initiate transformation, at least partially through the
ability of NF-kB to suppress transformation-associated apoptosis. In this study, we show that oncogenic H-Ras
requires PI3K and Akt to stimulate the transcriptional activity of NF-kB. Activated forms of H-Ras and MEKK
stimulate signals that result in nuclear translocation and DNA binding of NF-kB as well as stimulation of the
NF-kB transactivation potential. In contrast, activated PI3K or Akt stimulates NF-kB-dependent transcription
by stimulating transactivation domain 1 of the p65 subunit rather than inducing NF-kB nuclear translocation
via IkB degradation. Inhibition of IkB kinase (IKK), using an IKKb dominant negative protein, demonstrated
that activated Akt requires IKK to efficiently stimulate the transactivation domain of the p65 subunit of NF-kB.
Inhibition of endogenous Akt activity sensitized cells to H-Ras(V12)-induced apoptosis, which was associated
with a loss of NF-kB transcriptional activity. Finally, Akt-transformed cells were shown to require NF-kB to
suppress the ability of etoposide to induce apoptosis. Our work demonstrates that, unlike activated Ras, which
can stimulate parallel pathways to activate both DNA binding and the transcriptional activity of NF-kB, Akt
stimulates NF-kB predominantly by upregulating of the transactivation potential of p65.
Akt, also known as PKB (protein kinase B) (3, 13), is a
serine/threonine protein kinase that has been shown to regu-
late cell survival signals in response to growth factors, cyto-
kines, and oncogenic Ras (19, 23, 40). Akt becomes activated
via the phosphoinositide-3-OH kinase (PI3K) pathway (18, 24,
29) and by other upstream kinases, including the recently iden-
tified Ca21- and calmodulin-dependent kinase protein kinase
kinase (64). Akt inhibits cell death pathways by directly phos-
phorylating and inactivating proteins involved in apoptosis,
including Bad, procaspase 9, and members of the Forkhead
transcription factor family (7, 8, 15, 16, 36, 55). Phosphoryla-
tion of Bad by Akt at serine (Ser) residues 112 and 136 enables
the 14-3-3 protein to interact with and sequester the inacti-
vated Bad protein in the cytoplasm (15, 67). Akt also phos-
phorylates the procaspase 9 protease at Ser-196, which has
been shown to contribute to the resistance of Ras-transformed
cells to overcoming apoptotic agents (8). Finally, members of
the Forkhead transcription factor family have been shown to
be directly phosphorylated by Akt (7, 36, 55) and the inactiva-
tion of the Forkhead family member FKHRL1 promotes cell
survival (7). In addition to directly phosphorylating and inac-
tivating proapoptotic protein targets, Akt can stimulate signal-
ing pathways that upregulate the activity of the transcription
factor NF-kB (31, 44, 49, 52). Importantly, the antiapoptotic
signals elicited by platelet-derived growth factor (PDGF) were
shown to require Akt-induced NF-kB transcriptional activity
(49).
Classical NF-kB, a heterodimer composed of p50 and p65
subunits, is a potent activator of gene expression from NF-kB
sites due to the presence of transactivating domains located in
the C-terminal 120 amino acids of the p65 (also called RelA)
protein (1, 21). Thus, NF-kB is regulated through mechanisms
that target the transcription function of NF-kB (22, 47, 58, 68,
69). Additionally, NF-kB activity is also regulated by the IkB
family of proteins that interact with and sequester the tran-
scription factor in the cytoplasm. Following cellular stimula-
tion, IkB proteins become phosphorylated by the multisubunit
IkB kinase (IKK) complex, which subsequently targets IkB for
ubiquitination and degradation by the 26S proteasome (66).
IKK-dependent degradation of IkB liberates NF-kB, allowing
this transcription factor to translocate to the nucleus, where
it upregulates transcription (1, 25). Thus, as is the case with
several transcription factors, NF-kB is regulated through sig-
naling mechanisms that control nuclear translocation (such as
IKK) and through mechanisms that are responsible for up-
regulating the transactivation function of NF-kB.
We have previously demonstrated that oncogenic Ras stim-
ulates NF-kB-dependent transcription (20) and that NF-kB is
required for Ras-mediated transformation (22). Moreover,
Ras activates NF-kB to suppress oncogene-induced apoptosis
(41). NF-kB was originally found to be required to block apo-
ptosis in response to tumor necrosis factor (TNF) (2, 37, 56,
57) and in response to genotoxic agents (57–59). Subsequently,
it was shown that NF-kB blocks TNF-induced apoptosis
through the transcriptional activation of genes encoding anti-
apoptotic proteins (12, 26, 57, 58, 59a, 70). Although we have
demonstrated that oncogenic Ras upregulates NF-kB to sup-
press Ras-induced apoptosis, the signaling pathways utilized
for NF-kB-dependent cell survival under these conditions have
not been elucidated. Because Akt provides a strong cell sur-
vival signal in response to activated Ras signaling (33, 34), we
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asked whether H-Ras(V12) utilizes Akt to activate NF-kB and
to provide an antiapoptotic signal. Thus, we demonstrate that
H-Ras(V12) stimulates NF-kB-dependent transcription in a
PI3K- and Akt-dependent manner. Recently, several groups have
reported that PI3K and Akt are involved in the activation of
NF-kB in response to TNF, interleukin 1b (IL-1b), phorbol
myristate acetate (PMA), pervanadate, and PDGF signaling
(4, 5, 31, 44, 46, 49, 52). Several of these papers indicated that
IKK activity is involved in the ability of Akt to stimulate NF-kB
transcriptional activity (30, 44, 49), presumably through direct
mechanisms involving enhanced NF-kB nuclear translocation.
However, we found that constitutively activated forms of either
PI3K or Akt stimulated NF-kB transcriptional activity pre-
dominantly through signaling pathways that targeted the trans-
activation domain of the p65 subunit. Consistent with the im-
portance of Akt in cell survival, we found that the inhibition of
endogenous Akt activity resulted in a loss of NF-kB transcrip-
tional activity and sensitization of cells to H-Ras(V12)-induced
apoptosis. Moreover, Akt-induced resistance to etoposide is
mediated, in part, by the ability of this serine/threonine kinase
to upregulate the transcriptional activity of NF-kB. This study
indicates that in addition to inhibiting preexisting proapoptotic
proteins, like Bad, procaspase-9, and the Forkhead transcrip-
tion factors, Akt provides long-term cell survival signals by ac-
tivating pathways that target NF-kB-dependent transcription.
MATERIALS AND METHODS
Cell culture and reagents. Murine NIH 3T3 fibroblasts were grown in Dul-
becco modified Eagle medium (DMEM; Gibco/BRL) supplemented with 10%
calf serum (Hyclone Laboratories, Logan, Utah) and penicillin-streptomycin
unless otherwise indicated. Human 293T kidney and Rat-1 fibroblast cells were
grown in DMEM supplemented with 10% fetal bovine serum (FBS; Hyclone
Laboratories) and penicillin-streptomycin unless otherwise indicated in the fig-
ure legends. The H-Ras(V12)-inducible Rat1:iRas cell line has been described
previously (42). Oncogenic Ras was induced by the addition of 5 mM isopropyl-
b-D-thiogalactopyranoside (IPTG) to complete medium. Cells expressing dom-
inant negative forms of Akt were generated by transfecting Akt K179A mutants
into Rat-1:iRas cells. Stable transfectants were selected and subcloned in me-
dium containing 1 mg of puromycin (Sigma, St. Louis, Mo.) per ml. Clones were
verified by Western blotting using an Akt-specific rabbit polyclonal antibody
(New England Biolabs, Beverly, Mass.).
Plasmid constructs. 3x-kB luciferase (3x-kB-Luc) reporter constructs contain
four kB DNA binding consensus sites from the major histocompatibility complex
class I promoter fused upstream to firefly luciferase. Mutant 3x-kB-Luc reporter
constructs contain two inactivating base pair mutations in each kB site. The Gal4
luciferase (Gal4-Luc) constructs contain four Gal4 DNA consensus binding sites
derived from the Saccharomyces cerevisiae GAL4 gene upstream of luciferase,
and Gal4-p65 constructs have the yeast Gal4 DNA binding domain fused to the
transactivation domain of p65 (50). Activated PI3K and Akt as well as dominant
negative constructs have been described previously (34, 61).
Transfection and luciferase reporter assays. NIH 3T3 and 293T cells at 60 to
80% confluence were transiently transfected using the Superfect reagent (Qia-
gen, Valencia, Calif.) according to the manufacturer’s instructions. Briefly, plas-
mid constructs (1 mg of total DNA) were diluted in serum-free medium and
mixed with the Superfect reagent. Complexes were allowed to form for 10 min
before serum-containing medium was added to the mixture. The cells were
washed once with 13 phosphate-buffered saline (PBS) and Superfect-DNA
complexes were added to the cells and placed in a humidified incubator at 37°C
with 5% CO2. Three hours postaddition, cells were washed with 13 PBS and
replenished with fresh serum-containing medium. Twenty-four hours posttrans-
fection, cells were washed once with 13 PBS and lysed in Reporter Lysis Buffer
(Promega, Madison, Wis.) for 10 min at room temperature. Extracts were col-
lected and cleared by centrifugation at high speed. Rat-1:iRas cells expressing
mutant Akt constructs were similarly transfected. However, cells were growth
factor deprived in 0.5% serum for 12 to 18 h posttransfection and H-Ras(V12)
was induced by the addition of IPTG for 12 h prior to cell harvest. Protein
concentration was determined with the Bio-Rad (Hercules, Calif.) protein assay
dye reagent. Luciferase assays were performed on equal amounts of protein
(50 mg/sample). D-Luciferin was used as a substrate, and relative light units were
measured using an AutoLumat LB953 luminometer (Berthold Analytical Instru-
ments). Results were normalized to those with an internal b-galactosidase (b-
Gal)-expressing plasmid (pCMV-LacZ) by a b-Gal colorimetric assay followed
by spectrophotometric quantitation (Promega). In addition, cells transfected
with Akt or PI3K mutant constructs were cotransfected with pCMV-LacZ and
assayed for transfection efficiency and/or cell death by counting b-Gal-positive
cells as previously described (41).
EMSAs and Western blot analysis. Preparation of nuclear and cytoplasmic
extracts and electrophoretic mobility shift assays (EMSAs) were performed as
described previously (41). Briefly, nuclear extracts were prepared 48 h posttrans-
fection and incubated with [a-32P]dCTP-labeled, double-stranded probe contain-
ing a kB consensus site from the class I major histocompatibility complex pro-
moter. Labeled probe-nuclear extract complexes were incubated for 10 min at
room temperature and separated on a 5% polyacrylamide gel. Subsequently, the
gel was dried and exposed to X-ray film. Antibody supershift experiments were
performed as previously described (41). Western blot analysis was performed by
preparing whole-cell extracts in the presence of protease inhibitors. Total protein
(50 mg) was separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE) and transferred to nitrocellulose membranes. The in-
dicated primary antibodies were incubated for 30 min, washed, and visualized by
incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies
and enhanced chemiluminescence (ECL) reagents (Amersham, Piscataway, N.J.).
Apoptosis assays and adenovirus infections. Cell viability assays were per-
formed using Rat-1:iRas cells expressing dominant negative forms of Akt [Akt
(K179A)] and/or a vector control. Cells were split to subconfluence in medium
containing 2% FBS for 24 to 36 h. Subsequently, supernatants containing apo-
ptotic cells were centrifuged at low speed in a clinical centrifuge and washed
gently with serum-free medium. Pellets were resuspended in 150 ml of serum-free
medium, and apoptotic cells were counted under light microscopy using a mod-
ified improved heamacytometer. Modified terminal deoxynucleotidyltransferase-
mediated dUTP nicked-end labeling (TUNEL) assays were performed per the
instructions of the manufacturer (Boehringer Mannheim, Indianapolis, Ind.).
Adenovirus infections were performed as previously described (27). Briefly,
Rat1-1 or Rat-1:iRas cells were plated at a concentration of 5 3 105 cells/well in
2% FBS. Twelve to 18 h later, the medium was aspirated and replaced with 2%
medium plus FBS containing adenovirus encoding the super repressor (SR)
IkBa (Ad-SRIkBa) or adenovirus encoding the cytomegalovirus (CMV) pro-
moter but not IkBa (Ad-CMV) (control virus) at a concentration of 50 PFU/cell.
Infection proceeded for 1 h, and then 2 ml of medium plus 2% FBS was added
to the well with the addition of 5 mM IPTG, as indicated in the figures. Apoptotic
cells were counted and assayed by TUNEL 48 h after the initial infection.
Kinase assays. Akt activity was measured by a phosphorylation assay using the
Crosstide peptide (14) specific to the Akt phosphorylation sequence from GSK3
per the instructions of the manufacturer (Upstate Biotechnology, Lake Placid,
N.Y.). Briefly, Rat-1:iRas cells were grown to subconfluence and pretreated with
LY 294002 (10 mM) for 1 h and 5 mM IPTG was added for 12 h prior to harvest.
Immunoprecipitations were performed by combining 500 mg of protein with 4 mg
of Akt monoclonal antibody (New England Biolabs) and incubating with protein
A/E-agarose beads for 2 h at 4°C. Beads were washed and incubated with a PKA
inhibitor peptide (17 mM) and 100 mCi of [g-32P]dATP for 30 min at 30°C with
constant agitation. Supernatants were spotted onto P81 phosphocellulose mem-
branes, washed, and counted in a scintillation counter.
RESULTS
Activation of the PI3K pathway stimulates NF-kB-depen-
dent transcription. Ras directly interacts with effector targets,
including the serine/threonine kinase Raf, PI3K, and the ex-
change factor Ral.GDS (63). Each of these targets is required
for Ras-induced transformation (63). Since H-Ras(V12) is
known to activate NF-kB (9, 20, 22), it was important to elu-
cidate which Ras effector pathways were being utilized to stim-
ulate NF-kB-dependent transcription. To address this ques-
tion, NIH 3T3 cells were transiently cotransfected with an
NF-kB-responsive reporter (3x-kB-Luc) and with either the
empty vector control or plasmids bearing genes encoding var-
ious activated H-Ras effector mutants (63). As shown in Fig. 1,
the H-Ras(V12, C40) effector mutant, which activates PI3K
but not Raf or Ral.GDS, stimulated NF-kB-dependent tran-
scription as efficiently as activated H-Ras(V12) in NIH 3T3
cells. However, expression of either H-Ras(V12, S35) or H-
Ras(V12, G37), which activates either the Raf kinase or the
Ral.GDS exchange factor, respectively, was less effective at
stimulating the transcriptional activity of NF-kB (Fig. 1). Con-
sistent with this data, our laboratory has recently demonstrated
that the expression of the H-Ras(V12, C40) effector mutant
effectively stimulates the transcriptional activity of NF-kB (43).
These results suggested that H-Ras(V12) can activate NF-kB
through signaling pathways involving PI3K.
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H-Ras(V12) requires PI3K and Akt to upregulate the tran-
scriptional activity of NF-kB. Activation of PI3K is known to
stimulate at least two signal transduction pathways, one involv-
ing Rac and another involving Akt (28). Since we have recently
demonstrated the requirement of Rac in H-Ras(V12)-induced
activation of NF-kB (43) and since Akt signaling has been
clearly implicated in Ras-mediated cell survival (33, 34), we
were interested in determining whether an activated form of
either PI3K or Akt could stimulate the transcriptional activity
of NF-kB. NIH 3T3 cells were transiently transfected with an
NF-kB-responsive reporter and with expression constructs
bearing genes encoding activated forms of H-Ras(V12), PI3K,
or Akt. As shown in Fig. 2A, cells transfected with activated
PI3K or Akt constructs demonstrated an increase in NF-kB
transcriptional activity. These results were similar to transcrip-
tional levels observed in cells expressing H-Ras(V12) (Fig.
2A). The increases in 3x-kB-Luc reporter activities observed
following PI3K and Akt expression were not due to differences
in transfection efficiencies, since all luciferase values were nor-
malized to that of an internal b-Gal control. Moreover, cells
transfected with wild-type forms of H-Ras, PI3K, or Akt dis-
played a #2-fold increase in 3x-kB luciferase activity relative to
the level in vector control cells, indicating that the increase in
NF-kB transcriptional activity was associated with activated
forms of these proteins (data not shown).
FIG. 1. Stimulation of NF-kB-dependent transcription by the H-Ras(V12,
C40) effector mutant. NIH 3T3 cells were transiently cotransfected with an
NF-kB-responsive reporter (3x-kB-Luc, 0.5 mg) and with expression plasmids
bearing the gene encoding H-Ras(V12), H-Ras effector mutants, or an empty
vector control (VC) (1 mg each). Cell lysates were harvested 24 h posttransfec-
tion, and luciferase activity was assayed as described in Materials and Methods.
Data are presented as multiples of the level of activation obtained for the vector
control group, which was normalized to 1. Results are the means 6 standard
deviations of results of three independent experiments. (Gel) Total protein was
isolated from a representative transfection experiment, and immunoblot analysis
was performed for transgene expression. Protein samples (50 mg per lane) were
resolved on a 10% polyacrylamide gel, transferred to nitrocellulose, and probed
for hemagglutinin-tagged p21Ras proteins with a hemagglutinin-specific antibody
(BABCO, Berkeley, Calif.). Immunoblot assays for actin expression confirmed
that relatively equal amounts of proteins were loaded in each lane.
FIG. 2. H-Ras(V12) stimulates NF-kB-dependent transcription through PI3K-
and Akt-dependent pathways. (A) Activated forms of PI3K (PI3K*) and Akt
stimulate the transcriptional activity of NF-kB as effectively as H-Ras(V12). NIH
3T3 cells were cotransfected with the 3x-kB-Luc reporter (0.5 mg), an internal
control plasmid reporter (pCMV-LacZ, 1 mg), and various expression constructs
(1 mg each). Luciferase and b-Gal activities were assayed 24 h posttransfection,
and fold luciferase activity was determined by normalizing values to total protein
levels and to b-Gal enzyme levels. Results are expressed as multiples of the level
of activation obtained with the mutant 3x-kB-Luc reporter, which contains mu-
tated cis elements that are no longer capable of binding NF-kB. Data are
representative of results of at least three independent experiments, and the
means 6 standard deviations are shown. (Gel) Immunoblot analysis demon-
strates that transfected cells effectively express the various transgenes. (B) H-Ras
(V12)-induced NF-kB transcriptional activity requires PI3K- and Akt-dependent
signaling pathways. NIH 3T3 cells were transiently transfected with the 3x-kB-
Luc reporter (0.5 mg), in either the absence (2) or presence (1) of H-Ras(V12)
(1 mg). Additionally, cells were transfected with the empty vector control (VC)
or with expression constructs bearing genes encoding dominant negative PI3K
(DPI3K) or Akt (Akt T308A and Akt K179A, 1 mg each). Luciferase levels were
measured 24 h posttransfection in order to avoid potential pitfalls associated with
cell death. Data are multiples of the level of activation obtained with the mutant
3x-kB-Luc control, as described above. Results are representative of at least
three independent experiments and were normalized to an internal b-Gal-ex-
pressing plasmid. (Gel) Immunoblot analysis shows that transfected NIH 3T3
cells express the dominant negative P13K (DPI3K) and Akt (DN Akt) constructs.
(C) PI3K requires Akt to stimulate NF-kB-dependent transcription. NIH 3T3
cells were transfected with the 3x-kB-Luc reporter (0.5 mg), a vector control
(VC), activated PI3K (PI3K*), or dominant negative Akt (Akt K179A) (1 mg
each). Forty-eight h posttransfection whole-cell extracts were harvested and
assayed for luciferase activity. Results are plotted as multiples of the level of
activation of the vector control and are representative of three independent
experiments. The means 6 standard deviations are shown.
1628 MADRID ET AL. MOL. CELL. BIOL.
Based on these results, it was important to establish whether
oncogenic Ras required PI3K and/or Akt activities to stimulate
the transcriptional activity of NF-kB. NIH 3T3 cells were co-
transfected with the 3x-kB-Luc reporter and with either the
empty vector control or the plasmid bearing the gene encoding
H-Ras(V12). In addition, some groups were also transfected
with expression constructs bearing genes encoding dominant
negative forms of either PI3K or Akt [Akt(T308A) or Akt
(K179A)]. H-Ras(V12)-induced NF-kB transcriptional activa-
tion was inhibited in NIH 3T3 cells coexpressing dominant
negative forms of either PI3K or Akt (Fig. 2B). The ability of
dominant negative PI3K and Akt constructs to block H-Ras
(V12)-induced NF-kB activity was not due to cell death, since
luciferase levels were normalized to that of an internal b-Gal-
expressing reporter (pCMV-LacZ) (data not shown). Addi-
tionally, cell extracts were harvested 24 h posttransfection, a
time frame which precedes the induction of Ras-induced cell
death (41). This point is further supported by the observation
that expression of either dominant negative PI3K or Akt con-
structs did not repress the basal transcriptional activity of
NF-kB (Fig. 2B). Finally, the inability of H-Ras(V12) to stim-
ulate NF-kB-mediated transcription in the presence of the
dominant negative proteins was not due to a suppression of the
H-Ras(V12) expression vector, since cell extracts displayed
similar levels of protein expression (Fig. 2B). These results
indicate that H-Ras(V12) requires PI3K- and Akt-dependent
signal transduction pathways to stimulate the transcriptional
activity of NF-kB.
To elucidate whether PI3K activates NF-kB through an Akt-
dependent manner, additional transfection experiments were
performed. Consistent with previous results (Fig. 2A), expres-
sion of activated PI3K (PI3K*) upregulated the transcriptional
activity of NF-kB in NIH 3T3 cells (Fig. 2C). However, expres-
sion of the dominant negative Akt [Akt(K179A)] blocked
PI3K*-induced activation of NF-kB (Fig. 2C). Equal levels of
activated PI3K protein were expressed in transfected cells,
indicating that the inability of PI3K* to stimulate NF-kB tran-
scriptional activity was not due to suppression of the pCMV-
PI3K* expression vector (data not shown). These results indi-
cate that oncogenic H-Ras is capable of stimulating the
transcriptional activity of NF-kB through signaling pathways
that involve PI3K and Akt.
PI3K and Akt stimulate NF-kB by stimulating the transac-
tivation domain 1 (TAD 1) of the p65 subunit. NF-kB is reg-
ulated, in part, through a cellular process involving phosphor-
ylation and degradation of its inhibitory protein IkB, which
allows NF-kB to translocate to the nucleus and activate tran-
scription (1, 25). Upon cellular stimulation, signal transduction
pathways are activated and subsequently stimulate the activa-
tion of the IKK signalsome complex to phosphorylate the IkB
protein (66). To address whether PI3K or Akt could stimulate
NF-kB nuclear translocation and subsequent DNA binding,
293T cells were transiently transfected with expression con-
structs bearing genes encoding activated forms of H-Ras,
MEKK-1, PI3K, or Akt (M-Akt). Since 293T cells demonstrate
$70% efficiency of transfection, we are able to transfect cells
with plasmids bearing genes encoding the various transgenes,
isolate nuclear proteins, and then analyze these extracts for
nuclear NF-kB activity by performing EMSAs. Nuclear ex-
tracts isolated from TNF-stimulated cells were used as a pos-
itive control for NF-kB DNA binding activity. As shown in Fig.
3A, 293T cells expressing H-Ras(V12) or constitutively active
FIG. 2—Continued.
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MEKK-1 (DMEKK-1) demonstrated an increase in the DNA
binding activity of NF-kB, compared to that of cells transfected
with an empty vector control plasmid. This result is consistent
with those of previous reports demonstrating that both H-Ras
(V12) and DMEKK-1 can stimulate nuclear translocation and
DNA binding of NF-kB (41, 65). Expression of H-Ras(V12)
and DMEKK-1 in 293T cells induced DNA-protein complexes
which contained both p65 and p50, as detected by supershift
analysis (data not shown). Interestingly, nuclear extracts from
293T cells expressing an activated form of either PI3K or Akt
failed to demonstrate significant increases in NF-kB DNA
binding activity (Fig. 3A). Consistent with the inability of ac-
tivated PI3K to stimulate nuclear translocation of NF-kB, ex-
pression of plasmids bearing genes coding for H-Ras(V12,
C40) in 293T cells also failed to increase the DNA binding
activity of NF-kB (data not shown). The inability of activated
PI3K and Akt to stimulate NF-kB DNA binding in 293T cells
was not due to lack of protein expression (data not shown).
This effect was also not caused by the quality of the nuclear
extracts or the amount of proteins analyzed during EMSAs,
since reanalysis of nuclear extracts isolated from transfected
cells demonstrated similar levels of Oct-1 DNA-protein com-
plexes (Fig. 3A, bottom gel). These results demonstrate that
unlike with activated H-Ras or DMEKK-1, the expression of an
activated form of PI3K or Akt in 293T cells did not result in an
increase in NF-kB nuclear translocation and DNA binding
activity. In support of our results, Kane et al. failed to detect
nuclear translocation of NF-kB following the expression of
activated Akt in the absence of PMA induction (31).
Since the nuclear translocation of NF-kB is controlled, at
least in part, through IKK-dependent phosphorylation of IkB,
it was important to elucidate whether PI3K or Akt could stim-
ulate signaling pathways that would phosphorylate and de-
grade IkBa. This was an important issue to address in our cell
model system, since recent reports indicate that Akt controls
NF-kB activity though mechanisms involving IKK-dependent
phosphorylation and subsequent degradation of IkBa (31, 44,
49). To explore this possibility, NIH 3T3 cells were cotrans-
fected with plasmids bearing genes encoding Flag-tagged wild-
type IkBa and LacZ. Additionally, cells were cotransfected
with either the empty vector control or plasmids bearing genes
encoding H-Ras(V12), DMEKK-1, activated PI3K, or M-Akt.
As shown in Fig. 3B, the expression of H-Ras(V12) in NIH 3T3
cells resulted in the degradation of the Flag-tagged IkBa pro-
tein. However, cells expressing either activated PI3K or Akt
failed to stimulate signaling pathways that were associated with
FIG. 3. PI3K and Akt activate NF-kB by upregulating the transactivation potential of the p65 subunit. (A) Activated H-Ras(V12) and MEKK stimulate cellular
pathways which result in nuclear translocation and increased DNA binding of NF-kB. Human 293T cells were transiently transfected with the vector control (VC) or
activated forms of MEKK, H-Ras, Akt, or PI3K (PI3K*) (3 mg each). Nuclear extracts were prepared and EMSAs were performed to assess the presence of NF-kB
DNA binding activity. Nuclear extracts isolated from TNF-stimulated 293T cells (15 ng/ml for 15 min) served as a positive control for NF-kB DNA binding activity.
(Bottom) Nuclear extracts analyzed for NF-kB DNA binding activity were reanalyzed using a 32P-labeled Oct-1-specific double-stranded probe to confirm the quality
of the nuclear proteins. Note that the Oct-1-specific DNA-protein complex but not the free probe is shown. No Add, no addition. (B) IKKb or H-Ras(V12) expression
stimulates IkBa degradation. NIH 3T3 cells were transfected with plasmids bearing the genes encoding the Flag-tagged IkBa and His-tagged LacZ (2 mg each).
Additionally, cells were transfected with the vector control (VC) or with plasmids bearing genes encoding wild-type IKKb or activated forms of H-Ras, MEKK, PI3K,
or Akt (1 mg each). Forty-eight hours posttransfection, cells were lysed and proteins (80 mg per lane) were resolved by PAGE. Transfected IkBa protein was detected
using a Flag-specific antibody (M2; Sigma). Protein loading and transfection efficiencies were controlled by performing immunoblot analysis for His-tagged LacZ
expression within each experimental group (data not shown). (C) Activated PI3K and Akt stimulate the transactivation domain of NF-kB. NIH 3T3 cells were
transiently transfected with the Gal4-luciferase reporter (100 ng) and with plasmids bearing the genes encoding either Gal4-p65 or Gal4–Elk-1 (100 ng each). Cells were
also transfected with the empty vector control (VC) or activated H-Ras(V12), PI3K, or Akt. Luciferase levels were measured and expressed as multiples of the level
of activation of the empty vector control. Data presented are the means 6 standard deviations of results of three independent experiments.
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IkBa degradation (Fig. 3B). Expression of IKKb served as
positive control for inducing IkBa degradation. The differ-
ences in Flag-tagged IkBa protein levels observed in cells
transfected with various expression constructs were not due to
differences in plasmid transfection efficiencies, since cell ex-
tracts displayed similar levels of b-Gal protein (data not
shown). These results are consistent with our observations that
activated forms of PI3K or Akt alone are not capable of stim-
ulating signaling pathways that lead to the phosphorylation and
degradation of IkBa as well as subsequent nuclear transloca-
tion and the DNA binding activity of NF-kB (Fig. 3A and B).
In support of our observations, we failed to detect significant
activation of endogenous IKK activity in response to activated
PI3K or AKT in 293T cells (data not shown). However, cells
expressing H-Ras(V12) and DMEKK-1 proteins displayed in-
creased IKK activity (data not shown). Thus, we found that
activated forms of either PI3K or Akt when expressed alone do
not induce signaling pathways that are capable of stimulating
endogenous, IkBa-specific IKK activity, IkBa degradation, or
nuclear translocation and DNA binding of NF-kB.
Various cellular stimuli can activate NF-kB-dependent tran-
scription, at least in part, through mechanisms independent of
signaling pathways which influence nuclear translocation.
These signaling pathways stimulate the transactivation domain
of the p65 subunit of NF-kB, presumably by targeting basal or
induced levels of NF-kB in the nucleus (21, 47, 59a, 60, 68, 69).
Since activated forms of PI3K and Akt can increase the tran-
scriptional activity of NF-kB without stimulating nuclear trans-
location (Fig. 2A and 3A), we were interested in determining
whether these signaling molecules could activate NF-kB by
targeting TAD 1 of the p65 subunit. To address this question,
we used a plasmid bearing DNA encoding the Gal4-p65 fusion
protein, where sequences encoding the DNA binding domain
of Gal4 have been joined with sequences encoding TAD 1 of
p65 (50). This plasmid, when cotransfected with a Gal4-Luc
reporter, allowed us to determine whether cellular signals up-
regulate gene expression by specifically targeting TAD 1 of the
p65 subunit of NF-kB. NIH 3T3 cells were cotransfected with
a 4x-Gal4-Luc reporter, a Gal4-p65 expression construct, and
plasmids bearing genes encoding activated H-Ras(V12), PI3K,
or Akt. For control purposes, cells were also transfected under
the same conditions, except expression constructs bearing
genes encoding the Gal4–Elk-1 fusion protein were used in-
stead of Gal4-p65. As shown in Fig. 3C, activated PI3K and
Akt, as well as H-Ras(V12), stimulated TAD 1 of p65. Impor-
tantly, the ability of PI3K and Akt to activate TAD 1 of p65 was
specific, since Gal4–Elk-1-mediated activity was stimulated by
H-Ras(V12) but not by activated PI3K or Akt (Fig. 3C). These
results indicate that PI3K and Akt, like H-Ras(V12), stimulate
NF-kB by targeting TAD 1 of the p65 subunit. However, unlike
H-Ras(V12), which activates signal transduction pathways that
increase NF-kB transcriptional activity through both nuclear
FIG. 4. Activated PI3K and Akt stimulate the p65 transactivation domain of NF-kB in a manner dependent on IkB kinase. (A) Akt requires IKKb to activate
NF-kB-dependent transcription. NIH 3T3 cells were transfected with the 3x-kB-Luc reporter (0.5 mg) and with the empty vector control (VC), M-Akt, or dominant
negative IKKb (DN IKKb) alone or with M-Akt plus DN IKKb (1 mg each). Forty-eight hours posttransfection, whole-cell extracts were harvested and assayed for
luciferase activity. Results are plotted as multiples of the level of activation obtained with the vector control and are averages 6 standard deviations of results of three
independent experiments. (B) Akt requires IKK to stimulate TAD 1 of the p65 subunit of NF-kB. NIH 3T3 cells were transfected with the Gal4-luciferase reporter,
Gal4-p65 (100 ng each), and the indicated constructs described above (1 mg each). Results are expressed as multiples of the level of activation obtained with the vector
control. The data are the means 6 standard deviations of results of three independent experiments. (Gel) Western blot analysis of transfected Gal4-p65. Whole-cell
extracts of the transfections described above (25 mg of protein each) were separated by SDS–10% PAGE, transferred to nitrocellulose, and assayed with an antibody
specific for the Gal4 DNA binding domain (sc-510; Santa Cruz Biotech, Santa Cruz, Calif.). Primary antibodies were detected using an HRP-labeled secondary antibody
and by performing ECL.
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translocation and an increased p65 transactivation potential,
PI3K and Akt upregulate primarily the transactivation poten-
tial of the p65 subunit of NF-kB. Consistent with this hypoth-
esis, we detected basal levels of nuclear NF-kB in proliferating
cells used in our experiments (data not shown). These findings
suggest that PI3K and Akt stimulate the transcriptional activity
of NF-kB by targeting basal levels of nuclear NF-kB and that
these molecules effectively upregulate the transactivation po-
tential of this transcription factor.
Activated Akt requires IKK to upregulate the transactiva-
tion domain of the p65 subunit of NF-kB. In order to further
explore a possible role of the IKK signalsome in Akt-induced
activation of NF-kB, we were interested in determining wheth-
er Akt required IKK to regulate NF-kB transcriptional activity.
To answer this question, NIH 3T3 cells were either transiently
transfected with the 3x-kB-Luc reporter or cotransfected with
plasmids bearing genes encoding the Gal4-p65 and the Gal4-
Luc reporters. In addition, cells were transfected with the vec-
tor control or with plasmids bearing the gene encoding M-Akt,
dominant negative IKKb, or M-Akt plus dominant negative
IKKb. Consistent with the ability of IKK to control NF-kB
nuclear translocation, NIH 3T3 cells expressing the dominant
negative IKKb protein displayed reduced basal 3x-kB lucif-
erase activity (Fig. 4A). These results suggest that dominant
negative IKKb blocked the accumulation of basal nuclear NF-
kB activity. However, as shown in Fig. 4A, the expression of
dominant negative IKKb in NIH 3T3 cells blocked M-Akt-
induced activation of NF-kB, suggesting that M-Akt required
endogenous IKK activity to regulate NF-kB transcriptional
activity. Since Akt did not induce nuclear localization of NF-
kB and since IKK activity has been implicated in controlling
Akt activity (31, 44, 49), we were interested in determining
whether IKK activity was required for Akt to stimulate TAD 1
of the p65 subunit of NF-kB. As shown in Fig. 4B, expression
of dominant negative IKKb blocked the ability of M-Akt to
stimulate the transactivation potential of the Gal4-p65 protein.
Importantly, expression of the dominant negative IKKb pro-
tein did not block expression of Gal4-p65 (Fig. 4B, gel). The
ability of dominant negative IKKb to block Gal4-p65 activity
was somewhat unexpected, because Gal4-p65 transcriptional
activity is not under the control of IkB-dependent phosphor-
ylation and degradation events. The loss of Gal4-p65-induced
luciferase activity in NIH 3T3 cells cotransfected with M-Akt
and dominant negative IKKb was not due to the ability of
dominant negative IKKb to inhibit pCMV-M-Akt expression,
since relatively equal amounts of hemagglutinin-tagged Akt
were observed (data not shown). Our results suggest that Akt
activation alone does not induce NF-kB through mechanisms
involving IkB degradation. Instead, our data indicate that Akt
requires IKK to modulate TAD 1 of p65 through mechanisms
independent of IkB phosphorylation and degradation (see Dis-
cussion). These results may explain, at least to some degree,
the observed dependence of IKK activity on Akt-dependent
induction of NF-kB activity (31, 49).
H-Ras(V12) requires Akt to stimulate the NF-kB transacti-
vation potential and to suppress oncogene-induced apoptosis.
In order to investigate the physiological relevance of NF-kB
activation by Akt, it was important to inhibit endogenous
Akt activities under conditions in which H-Ras(V12) was ex-
pressed. To experimentally address this point, we used the
inducible Rat-1:iRas cell line, which contains stably integrated
H-Ras(V12) under the control of an IPTG-responsive pro-
moter (42). This cell line has been used previously to demon-
strate that NF-kB provides a cell survival role in H-Ras(V12)
signaling (41). Rat-1:iRas cells were transfected with a plasmid
bearing the gene encoding the dominant negative Akt(K179A)
protein, and stable clones were generated. As shown in Fig.
5A, Rat-1:iRas–dominant negative Akt clones which expressed
similar levels of the dominant negative Akt(K179A) protein
were selected. Additionally, Rat-1:iRas–dominant negative
FIG. 5. Characterization of Rat-1:iRas cells expressing a dominant negative
Akt protein. (A) Characterization of the Rat-1:iRas–dominant negative Akt
cells. Rat-1:iRas cells etopically expressing a plasmid bearing the gene encoding
the dominant negative Akt(K179A) protein (DN Akt) or the vector control were
generated, as described in the Materials and Methods. Total protein (50 mg) was
isolated from Rat-1:iRasV cells (vector control cells), three Rat-1:iRas–domi-
nant negative Akt clones (.5, .7, and .15), and Rat-1:iRas–dominant negative
Akt-P cells (Pool) in the absence or presence of IPTG (5 mM). Protein samples
were resolved on an SDS–10% polyacrylamide gel, transferred to membrane,
and analyzed for the presence of Akt, Ras, and a-tubulin. Akt(K179A) protein
was detected using a hemagglutinin-specific antibody (BABCO). IPTG-induced
p21Ras expression was detected using a pan-Ras monoclonal antibody (Calbio-
chem, San Diego, Calif.). To ensure equal levels of protein loading, blots were
reanalyzed with an a-tubulin-specific antibody (Sigma). Primary antibodies were
detected using an HRP-labeled secondary antibody and by performing ECL. (B)
Expression of the dominant negative Akt protein blocks H-Ras(V12)-induced
endogenous Akt activity. Subconfluent Rat-1:iRasV and Rat-1:iRas–dominant
negative Akt-P cells were grown overnight in medium containing 2% FBS.
Eighteen hours later cells were washed and cultured for 4 h without serum and
with or without IPTG (5 mM). Some groups received LY 294002 (10 mM) 3 h
after serum deprivation. Immunocomplex kinase assays for Akt were performed
as described in Materials and Methods. The fold Akt activity was determined by
obtaining values for Rat-1:iRasV and Rat-1:iRas–dominant negative Akt-P cells
(grown in the absence of IPTG) and normalizing these numbers to 1. Data
presented are representative of results of at least three different assays, which
generated similar results. (Gel) Immunoblot analysis demonstrating that rela-
tively equal amounts of total Akt protein were immunoprecipitated during the
course of the experiment. Both endogenous Akt and hemagglutinin-tagged dom-
inant negative Akt(K179A) proteins are shown.
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Akt stable clones displayed levels of IPTG-induced H-Ras
expression similar to that of the vector control cells (Rat-1:
iRasV) (Fig. 4A). Rat-1:iRas–dominant negative Akt clones
(namely, .5, .7, and .15) were combined to create a pooled cell
line (Rat-1:iRas–dominant negative Akt-P) (Fig. 5A).
To determine whether cells expressing the dominant nega-
tive Akt(K179A) protein displayed a reduction in H-Ras(V12)-
induced Akt activity, immune complex kinase assays were per-
formed using Crosstide as an Akt-specific peptide substrate
(14). As shown in Fig. 5B, Rat-1:iRasV control cells dem-
onstrated a fourfold increase in Akt activity following IPTG-
induced H-Ras(V12) expression. In contrast, Rat-1:iRas–
dominant negative Akt-P cells, constitutively expressing Akt
FIG. 6. The inhibition of endogenous Akt activity sensitizes cells to H-Ras
(V12)-induced apoptosis. (A) Expression of H-Ras(V12) is associated with an
increase in apoptosis in cells expressing the dominant negative Akt protein (DN
Akt). Rat-1:iRasV, Rat-1:iRas–dominant negative Akt clones (.5, .7, and .15),
and Rat-1:iRas–dominant negative Akt-P cells (pooled clone) were grown over-
night in medium containing a reduced concentration of serum (2% FBS). Eigh-
teen hours later, cells were treated in either the absence or presence of IPTG
(5 mM). Apoptotic cells were harvested from the supernatants 48 h after IPTG
addition, fixed in paraformaldehyde, and stained with Hoechst dye, and cells
displaying nuclear fragmentation and condensation were counted, as described
in Materials and Methods. Results are expressed as numbers of apoptotic cells
(means 6 standard deviations). Assays were repeated at least three independent
times. (B) Rat-1:iRasV and Rat-1:iRas–dominant negative Akt-P cells were
cultured and stimulated with IPTG as described above. Cell morphologies were
analyzed 48 h after IPTG addition. Paraformaldehyde-fixed cells were analyzed
for apoptosis by performing TUNEL analysis (Boehringer Mannheim). The
upper four images show phase-contrast microscopy (magnification, 320). The
bottom four images show fluorescence microscopy of TUNEL-positive cells
(magnification, 340). (C) H-Ras(V12) no longer stimulates the p65 transactiva-
tion domain in cells stably expressing the dominant negative Akt protein. Rat-
1:iRasV and Rat-1:iRas–dominant negative Akt-P cells (pooled clone) were
transfected with the Gal4-luciferase reporter (100 ng) and with constructs bear-
ing the gene encoding the Gal4-p65 fusion protein (100 ng). Eighteen hours
following transfections, cells were stimulated with IPTG (5 mM). Twenty-four
hours following IPTG addition, cell extracts were isolated and luciferase activi-
ties were determined. Results are the averages 6 standard deviations from three
independent experiments performed in triplicate. (D) H-Ras(V12) stimulates
Gal4–Elk-1 in the vector control and cells expressing dominant negative Akt
[Akt(K179A)]. Cells were transfected with Gal4-luciferase and Gal4–Elk-1 (100
ng each). Twenty-four hours posttransfection, cells were incubated in either
DMEM containing 10% serum and IPTG (5 mM) or DMEM plus 10% serum
alone for an additional 24 h. Whole-cell extracts were isolated and assayed for
luciferase levels. Results are expressed as multiples of the level of activation
obtained with the vector control or dominant negative Akt-P without IPTG
incubation and are the averages 6 standard deviations of results of three
independent experiments performed in triplicate.
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(K179A) protein, failed to display increases in Akt kinase
activity following IPTG addition (Fig. 5B). Phosphorylation of
the crosstide by endogenous Akt was specific to IPTG-induced
H-Ras(V12) expression, and kinase activity was inhibited by
the PI3K inhibitor LY 294002 (Fig. 5B). Differences in kinase
activities between Rat-1:iRasV and Rat-1:iRas–dominant neg-
ative Akt-P cells were not due to unequal amounts of immuno-
precipitated Akt, since analysis of input protein demonstrated
that similar levels of protein were analyzed for the kinase ac-
tivity (Fig. 5B, gel). These results indicate that the expression
of the dominant negative Akt protein blocked the ability of
H-Ras(V12) to stimulate endogenous Akt activity in Rat-1:
iRas–dominant negative Akt-P cells.
To determine whether the loss of endogenous Akt activity
would sensitize cells to H-Ras(V12)-induced apoptosis in our
model system, Rat-1:iRasV and Rat-1:iRas–dominant negative
Akt clones were grown in complete medium containing a re-
duced concentration of serum (2% FBS) in either the absence
or presence of IPTG to induce H-Ras(V12) expression. Forty-
eight hours after IPTG addition, cellular supernatants contain-
ing detached cells were harvested, fixed, and stained with
Hoechst dye and cells displaying fragmented nuclei were
counted as described in Materials and Methods. As shown in
Fig. 6A, both Rat-1:iRasV and Rat-1:iRas–dominant negative
Akt clones displayed elevated basal apoptotic cell numbers
(without IPTG) when cells were cultured with a reduced con-
centration of serum (2% FBS). However, this effect was not
observed in cells cultured under normal conditions (10% FBS)
(data not shown). Consistent with the antiapoptotic nature of
Akt, we found that cells expressing the dominant negative Akt
(K179A) protein were more susceptible to H-Ras(V12)-in-
duced apoptosis than the control Rat-1:iRasV cells (Fig. 6A).
Compared to vector control Rat-1:iRasV cells, IPTG-induced
Rat-1:iRas–dominant negative Akt-P cells displayed enhanced
morphological signs of apoptosis, including retraction of cel-
lular processes, nuclear condensation, and loss of adherence
(Fig. 6B, top). Moreover, IPTG-induced H-Ras(V12) expression
stimulated apoptosis in Rat-1:iRas–dominant negative Akt-P
cells, as detected by the appearance of TUNEL-positive cells
(Fig. 6B, bottom). These results are consistent with reports
indicating that Akt provides a cell survival signal downstream
FIG. 7. M-Akt-transformed cells require NF-kB to block etoposide-induced apoptosis. (A) Generation of H-Ras(V12)- and M-Akt-transformed Rat-1 cells. Rat-1
cells stably expressing activated H-Ras(V12) or M-Akt were generated as described in Materials and Methods. Total protein (50 mg) was isolated from Rat-1:Hygro,
Rat-1:H-Ras(V12), and Rat-1:M-Akt cells, resolved by performing PAGE, and transferred to nitrocellulose membrane. Immunoblot analysis was performed to detect
transgenic expression of p21ras and M-Akt using the pan-Ras antibody or the hemagglutinin antibody, respectively. (B) The p65 transactivation domain is activated in
Rat-1 cells transformed with either H-Ras(V12) or M-Akt. Rat-1:Hygro, Rat-1:H-Ras(V12), and Rat-1:M-Akt cells were transiently transfected with a Gal4-luciferase
reporter (100 ng) and with constructs bearing the genes encoding Gal4-p65 (100 ng). Forty-eight hours following the start of transfection, cell extracts were harvested
and luciferase activities were determined. Data are the averages 6 standard deviations of results of three experiments performed in triplicate. (C) Rat-1:M-Akt cells
are resistant to apoptotic induction agents. Rat-1:Hygro and Rat-1:M-Akt cells were either left untreated (No Add) or given etoposide (15 mM) or staurosporine (50
mM). Apoptotic cell numbers were determined 18 h following the addition of either etoposide or staurosporine (Stauro). Results presented here are the means 6
standard deviations of results of two independent experiments performed in duplicate. (D) M-Akt requires NF-kB to overcome etoposide-induced apoptosis.
Rat1:M-Akt cells were cultured overnight in medium containing 2% FBS, after which cells were infected with either Ad-CMV or Ad-SRIkBa (50 PFU/cell). Six hours
following adenovirus-mediated gene delivery, cells were either left untreated (No Add) or treated with either etoposide (5 mM) or staurosporine (25 mM). Apoptotic
cell numbers were analyzed in etoposide-treated Rat-1:M-Akt cells over the time course indicated, while the apoptotic cell numbers detected for staurosporine were
analyzed 60 h after the drug addition. Data presented are the averages 6 standard deviations of results of two different experiments where the numbers of apoptotic
cells were counted in triplicate. (Gel) Immunoblot analysis demonstrating that Ad-SRIkBa is effectively expressed in the Rat-1 cell lines. IkBa proteins were detected
using a rabbit polyclonal antibody (C-21; Santa Cruz Biotech). Protein samples analyzed in lanes 1, 3, 5, and 7 are from Rat-1:M-Akt cells infected with Ad-CMV, while
those in lanes 2, 4, 6, and 8 are from cells infected with Ad-SRIkBa.
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of activated H-Ras (33, 48) and indicate that Akt is one of the
major antiapoptotic mediators of oncogenic Ras signaling.
To elucidate whether H-Ras(V12)-induced apoptosis, fol-
lowing the inhibition of Akt, was associated with a loss in
NF-kB transcriptional activity, transient-cotransfection assays
were performed. As shown in Fig. 6C, the addition of IPTG to
the control Rat-1:iRasV cells led to a subsequent increase in
H-Ras(V12)-induced Gal4-p65 transcriptional activity. How-
ever, Rat-1:iRas–dominant negative Akt-P cells failed to show
an increase in Gal4-p65 transcriptional activity following IPTG-
induced H-Ras(V12) expression (Fig. 6C). To show that Akt-
mediated signaling pathways defective in Rat-1:iRas–dominant
negative Akt-P cells were specific for Gal4-p65, similar exper-
iments were performed using Gal4–Elk-1. Rat-1:iRas–dom-
inant negative Akt-P and vector control cells were capable
of stimulating Gal4–Elk-1 activity following IPTG-induced
H-Ras(V12) expression (Fig. 6D). Thus, cells expressing the
dominant negative Akt (K179A) still retain the ability to signal
to other Ras effector pathways. Collectively, our results indi-
cate that the inhibition of endogenous Akt activity is associated
with a loss of H-Ras-induced NF-kB-dependent transcription
and enhanced susceptibility of these cells to apoptosis.
Akt-transformed Rat-1 cells require NF-kB to suppress apo-
ptosis induced by etoposide. Although our data implicate NF-
kB as a downstream mediator of the Akt cell survival response,
we needed to determine whether the ability of Akt to tran-
scriptionally upregulate NF-kB contributes to the antiapopto-
tic function of this kinase. To address this point, we made sta-
ble cell lines which expressed activated forms of Ras [Rat-1:
H-Ras(V12)] or Akt (Rat-1:M-Akt) or which contained the
vector control plasmid (Rat-1:hygro [Hygro]). As shown in Fig.
7A, Rat-1 clones which express relatively equal levels of either
H-Ras(V12) or M-Akt were selected. Unlike the Rat-1:Hygro
control cells, both Rat-1:H-Ras(V12) and Rat-1:M-Akt cells
displayed characteristics of transformed cells, as indicated by
their abilities to form foci and to grow in soft agar (data not
shown). Consistent with transient-transfection assays (Fig. 3C),
we found that both Rat-1:H-Ras(V12) and Rat-1:M-Akt cells
displayed elevated Gal4-p65 transcriptional activity, compared
to that of the Rat-1:Hygro control cells (Fig. 7B). These results
are consistent with the ability of H-Ras(V12) and M-Akt to
stimulate NF-kB by targeting TAD 1 of the p65 subunit.
To further confirm that NF-kB is a downstream target of
Akt, we took advantage of the fact that it has been recently
demonstrated that Akt provides a cell survival signal that
blocks apoptosis initiated by the PKC inhibitor, staurosporine,
or by the topoisomerase II inhibitor, etoposide (8). Impor-
tantly, unlike staurosporine, which does not activate NF-kB
(58), etoposide is known to stimulate endogenous NF-kB-re-
sponsive gene transcription (32, 59a). To determine whether
M-Akt expression provides a cell survival function in response
to proapoptotic agents, Rat-1:Hygro and Rat-1:M-Akt cells
were treated in either the absence or presence of etoposide (15
mM) or staurosporine (50 mM) and apoptotic cell numbers
were determined 18 h after drug addition. As shown in Fig.
7C, Rat-1:M-Akt cells were more resistant to etoposide- and
staurosporine-induced apoptosis than the Rat-1:Hygro control
cells. These results are consistent with previous findings dem-
onstrating that activated Akt is capable of suppressing apopto-
sis by phosphorylating and inactivating procaspase-9 (8). The
addition of etoposide to Rat-1:M-Akt cells stimulated NF-kB-
induced transcription in transient-transfection assays. How-
ever, staurosporine was unable to stimulate the transcriptional
activity of NF-kB in these cells (data not shown). Therefore,
despite the ability of M-Akt to overcome apoptosis induced by
etoposide and staurosporine, only etoposide-induced stress
signals are capable of activating NF-kB.
To determine whether M-Akt-transformed cells required
NF-kB to suppress apoptosis in response to etoposide, we used
the SR IkBa (6). This mutant IkBa protein acts as a trans-
dominant negative protein because it binds to NF-kB and in-
hibits nuclear translocation and DNA binding (41, 47, 57).
Importantly, expression of the SR IkBa protein blocks the ac-
tivation of NF-kB-responsive genes (27, 58). Rat-1:M-Akt cells
were infected with Ad-SRIkBa or with Ad-CMV, and cells
were treated with either etoposide or staurosporine. Adeno-
virus-mediated delivery of transgenes is extremely effective in
Rat-1:M-Akt cells, where $95% of cells effectively express
transgenes 12 h following viral infection (Fig. 7D, gel, and data
not shown). Rat-1:M-Akt cells were more susceptible to etopo-
side-induced apoptosis following the inhibition of NF-kB by
Ad-SRIkBa than cells infected with Ad-CMV (control virus)
FIG. 7—Continued.
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(Fig. 7D). However, compared to Rat-1:Hygro control cells,
Rat-1:M-Akt cells were more resistant to apoptotic signals
induced by etoposide even after the inhibition of NF-kB tran-
scriptional activity (data not shown). Although NF-kB func-
tions as a cell survival factor, these results suggest that other
NF-kB-independent pathways which provide strong antiapo-
ptotic signals exist. Therefore, we presume that since Rat-1
cells express both Bad and caspase-9, these downstream targets
are likely to be controlled by H-Ras(V12)-induced Akt activity
in the absence of NF-kB transcriptional activity. Although
Rat-1:M-Akt cells were more resistant to apoptosis induced by
staurosporine, the expression of SR-IkBa did not sensitize
staurosporine-treated cells to programmed cell death (Fig. 7D,
inset). These results indicate that Rat-1:M-Akt cells require
NF-kB to overcome proapoptotic death pathways induced by
etoposide but not signals stimulated by staurosporine. Thus,
Akt is an important antiapoptotic signaling molecule that con-
tributes to cell survival not only by directly phosphorylating
proapoptotic targets but also by stimulating the transcriptional
activity of NF-kB.
DISCUSSION
The data presented here indicate that one mechanism
whereby Akt-controlled signaling pathways inhibit apoptosis is
through the activation of the transcription factor NF-kB. Loss
of endogenous Akt is associated with a downregulation in the
transcriptional activity of NF-kB and with H-Ras(V12)-in-
duced apoptosis. Moreover, we find that activated Akt requires
NF-kB to partially suppress etoposide-induced apoptosis. Con-
sistent with previous findings which demonstrate that Akt can
inhibit multiple proapoptotic molecules through direct phos-
phorylation events (7, 8, 15, 16, 36), we found that the loss of
NF-kB transcriptional activity did not completely sensitize
Akt-expressing cells to apoptosis in response to etoposide (Fig.
7D). Thus, our work and the work of others indicate that Akt
mediates cell survival signals through immediate phosphoryla-
tion of proapoptotic proteins and through longer-term tran-
scription-dependent mechanisms. These findings are consistent
with extensive evidence for an antiapoptotic role for NF-kB in
blocking certain apoptotic stimuli and indicate that NF-kB is a
downstream target of Akt-induced cell survival signals.
We explored the potential involvement of Akt as a mediator
in signaling between oncogenic Ras and NF-kB. Oncogenic
Ras has been demonstrated to induce both proapoptotic and
antiapoptotic signals (40, 51), and we have shown previously
that oncogenic Ras stimulates the transcriptional activity of
NF-kB to overcome H-Ras(V12)-induced apoptosis (41).
Since both PI3K and Akt have been shown to provide an
antiapoptotic signal in response to oncogenic Ras expression,
we asked whether PI3K and Akt provide the link to NF-kB
activation. In this study, we have found that H-Ras(V12) re-
quires the antiapoptotic pathways involving PI3K and Akt to
stimulate the transcriptional activity of NF-kB. Consistent with
this, we demonstrate that inhibition of endogenous Akt kinase
activity suppresses H-Ras(V12)-induced NF-kB transcription
and sensitizes cells to apoptosis. Although Akt was required to
suppress apoptosis induced by H-Ras(V12), Ras is able to
utilize additional signaling pathways to activate NF-kB-depen-
dent cell survival. This supposition is supported by our obser-
vations that inhibition of NF-kB with the SR IkBa further
sensitized Rat-1:iRas–dominant negative Akt-P cells to Ras-
mediated apoptosis (data not shown). Interestingly, unlike H-
Ras(V12), M-Akt-transformed cells did not undergo apoptosis
following the inactivation of NF-kB with the SR IkBa protein
(data not shown). This observation suggests that, unlike H-Ras
(V12), activated Akt does not stimulate signaling pathways
which induce cell death. An alternative possibility, however, is
that the overexpression of M-Akt is such a powerful antiapo-
ptotic factor that it overcomes programmed cell death signals
following the inactivation of NF-kB. Nevertheless, the evi-
dence that Akt-induced activation of NF-kB provides a cell sur-
vival function is shown by the ability of NF-kB to protect Akt-
expressing cells from etoposide-induced apoptosis (Fig. 7D).
The regulation of NF-kB by Akt is likely to be important in
cytokine and growth factor signaling, since many of the phys-
iological inducers of Akt also stimulate the transcriptional
activity of NF-kB. Recently, physiological stimuli, including
TNF-a, IL-1b and PDGF, have been shown to activate NF-kB
in a PI3K- and Akt-dependent manner (31, 44, 49, 52). It is
intriguing that the cell survival mechanisms and potentially
the mitogenic pathways associated with growth factor signaling
is controlled, at least partially, by NF-kB-dependent mecha-
nisms. Consistent with this point, we and others (27, 30) have
recently shown that NF-kB can promote cell growth by con-
trolling the transcription of the cyclin D1 gene. It will be im-
portant to determine if Akt-derived mitogenic signals involve
the transcription function of NF-kB, possibly through the con-
trolled upregulation of cyclin D1 or other functionally related
proteins.
Previous work has indicated that PI3K and Akt are involved
in NF-kB activation. For example, it was shown (4) that acti-
vation of NF-kB in response to the tyrosine phosphatase in-
hibitor pervanadate was blocked by the PI3K inhibitor wort-
mannin. It was proposed that tyrosine-phosphorylated IkBa
associated with the p85 subunit of PI3K, allowing nuclear
translocation of NF-kB. In that study, wortmannin did not
block the ability of TNF to induce nuclear translocation of
NF-kB. Stark and colleagues have shown recently (52) that
IL-1b stimulates the association of the IL-1 receptor accessory
protein with the p85 subunit of PI3K and that, consistent with
our results, this leads to the stimulation of the transactivation
potential of the p65 subunit of NF-kB. Interestingly, it was
shown that this response also leads to phosphorylation of
the p65 subunit, but the site of this phosphorylation was not
mapped. Additionally, Kane and colleagues (31) have shown
that Akt expression augmented the ability of PMA to activate
NF-kB through enhanced IkBa phosphorylation and degrada-
tion. The ability of Akt to synergize with PMA on the activa-
tion of an NF-kB promoter was blocked by a kinase-inactive
IKK. Interestingly, Akt was unable to activate NF-kB nuclear
translocation on its own, consistent with our data. More re-
cently, two reports implicate Akt in NF-kB activation induced
by TNF (44) and by PDGF (49). Several such reports implicate
IKK activity as being required for the Akt-controlled response.
Our data indicate that Akt activation alone is insufficient to
activate endogenous IKK activity and NF-kB nuclear translo-
cation. However, our data demonstrate that Akt signals to a
pathway that stimulates the transcriptional potential of the p65
subunit of NF-kB through activation of TAD 1. Even though
Akt is a serine/threonine kinase, it is unlikely that this protein
directly phosphorylates p65 since the TAD 1 region does not
contain consensus Akt phosphorylation sites. Moreover, we
have been unsuccessful at detecting protein-protein interac-
tions between p65 and Akt. (L. V. Madrid, A. S. Baldwin, Jr.,
and M. W. Mayo, unpublished observations). However, mu-
tation of serine 529 in TAD 1 of p65, which is known to be
phosphorylated in response to TNF signaling (60), inhibits the
ability of Akt to activate p65 transcription. (Madrid et al.,
unpublished observations). As mentioned earlier, and in ap-
parent contrast with reports which indicate that the role of Akt
in inducing NF-kB activity occurs through IKK-dependent
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degradation of IkBa (31, 44, 49), the overexpression of acti-
vated Akt is unable to stimulate endogenous IKK activity or
IkBa degradation (Fig. 3B and data not shown). In contrast,
H-Ras(V12) expression in cells is able to stimulate endogenous
IKK activity, induce degradation of IkBa, and increase nuclear
translocation and DNA binding of NF-kB (Fig. 3A and B and
data not shown). These results suggest that H-Ras(V12) regulates
NF-kB through two signals: one that leads to nuclear localiza-
tion of NF-kB and one that activates the transactivation func-
tion of the p65 subunit. Although M-Akt does not stimulate
endogenous IKK activity directed towards IkBa degradation,
the IKK signalsome complex is still important in regulating the
ability of Akt to stimulate NF-kB. This hypothesis is supported
by the observation that a dominant negative IKKb protein
inhibited the ability of Akt to stimulate TAD 1 of p65 (Fig.
4B). These results suggest that IKK activity (possibly indepen-
dent of IkBa phosphorylation) or some structural aspect of
IKK is required for the ability of Akt to stimulate NF-kB
transactivation function. The fact that Gal4-p65 is not regu-
lated through an IkB-dependent mechanism suggests that IKK
is required for Akt to activate TAD 1 of p65, independent of
nuclear translocation signals. Collectively, these results suggest
that the IKK signalosome complex is capable of regulating
NF-kB through signaling events involved in nuclear transloca-
tion as well as Akt-induced transactivation pathways. Although
our data indicate that Akt alone is unable to stimulate IkBa
degradation on its own, they do not rule out the possibility that
Akt is required (but not sufficient) for activation of IkBa
phosphorylation and degradation in response to certain signal
transduction cascades.
Our results demonstrating that H-Ras(V12) requires PI3K
and Akt to stimulate NF-kB-dependent transcription and cell
survival are very likely to be important in cancer biology. Hu-
man tumors displaying upregulated endogenous Akt (10, 11,
23) or lacking tumor suppressor gene products which modulate
PI3K activities, such as the PTEN phosphotidylinoside phos-
phatase (39, 53), may utilize elevated transcriptional activities
of antiapoptotic and proproliferative transcription factors, like
NF-kB, to enhance oncogenic potential. Therefore, loss of
PTEN, which occurs in a variety of tumors (17, 37, 45, 54, 62),
is predicted to lead to the upregulation of NF-kB, providing
signals potentially relevant to oncogenesis (27, 41).
The data provided here are consistent with those of other
reports indicating that transforming events which upregulate
Akt activity have profound effects not only on cell survival in
terms of oncogenesis but also on chemoresistance. Along these
lines, the activation of Akt in tumor cells may synergize with a
chemotherapeutic response (such as that induced by etopo-
side) to provide an enhanced antiapoptotic function. Thus, the
induction of NF-kB nuclear translocation by etoposide plus an
Akt signal to stimulate transactivation function may lead to a
potent antiapoptotic response through enhanced regulation of
antiapoptotic genes. In support of this point, we demonstrate
that M-Akt provides resistance to the apoptotic agent etopo-
side and that M-Akt-mediated resistance to etoposide requires
the transcriptional activity of NF-kB. Since NF-kB functions
to positively upregulate gene products which are known to
overcome chemotherapy-induced apoptosis, such as c-IAP1,
c-IAP2, and A1 (12, 26, 58, 59a, 70), future experiments will
determine whether constitutively active Akt potentiates che-
moresistance by regulating expression of NF-kB-controlled
antiapoptotic gene products.
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